Alcohol Dependence Clinical Trial
Official title:
Enhanced MI With Alcohol Positive Trauma Patients
The primary goal of this study is to test the efficacy of a brief intervention that includes the patient and a significant other, relative to an intervention including the patient only, for reducing alcohol use and alcohol-related problems among trauma patients.
Alcohol-positive trauma patients are more likely to be readmitted to a trauma center or
subsequently die from an injury than are alcohol-negative patients. Empirically supported
treatments to reduce alcohol use and alcohol-related problems (e.g., injuries, drinking and
driving) in this high-risk population are needed, but few exist. This randomized controlled
clinical trial assesses the efficacy of a brief intervention that includes the patient and a
significant other, relative to an intervention including the patient only, for reducing
alcohol use and alcohol-related problems among trauma patients.
Motivational Interviewing (MI), a brief, directive, non-confrontational intervention, has
demonstrated some promise in this setting. Further, inclusion of a significant other (SO) in
prolonged, intensive alcohol treatment appears to improve treatment retention and efficacy.
Although inclusion of an SO in MI has been suggested, there are few data to support this
endorsement.
Accordingly, this study will address whether motivational interviewing including both the
trauma patient and an SO can more effectively decrease and maintain reductions in alcohol
use and alcohol-related problems 6 and 12 months following discharge from the trauma unit
than MI with the individual patient or an assessment-only condition.
The 2 MI groups will each receive 2 intervention sessions timed to occur in the hospital,
and 1 booster session, occurring 1 month following discharge.
In the assessment-only condition, patients will receive only assessment of their drinking at
baseline. This proposal will allow us to address the next phase of our program of research
designed to develop easily disseminable treatments for these high-risk populations in
medical settings. This study will also address potential mediators (motivation to change
alcohol use, self-efficacy, alcohol treatment attendance, and social support for abstinence)
and moderators of MI effects. The cost-effectiveness of the intervention will also be
addressed.
Thus, this study will address both a significant public health problem and provide important
information about MI mechanisms that may be relevant to the broader addiction treatment
community.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02901041 -
Interdisciplinary Study of A Novel Anticonvulsant in Alcoholism
|
Phase 3 | |
Completed |
NCT03340051 -
Remote Alcohol Monitoring and Episodic Thinking
|
N/A | |
Not yet recruiting |
NCT06444243 -
Psilocybin-assisted Therapy for Alcohol Use Disorder
|
Phase 2 | |
Completed |
NCT02486900 -
Neurofeedback & Alcohol Dependence
|
N/A | |
Completed |
NCT02705898 -
Lifestyle Physical Activity Intervention for Depressed Alcohol Dependent Women
|
N/A | |
Completed |
NCT02179749 -
Mifepristone Treatment of Alcohol Use Disorder
|
Phase 2 | |
Completed |
NCT02197598 -
Treatment of Patients Suffering of Alcohol Dependence and Impaired Liver Function With Selincro® As-needed Use
|
Phase 4 | |
Recruiting |
NCT02385643 -
The Efficacy of A Smartphone-based Support System to Reinforce Alcohol Abstinence in Treatment-seeking Patients
|
N/A | |
Completed |
NCT01828866 -
Eye Movement Desensitization and Reprocessing (EMDR) in Alcohol Dependent Patients
|
N/A | |
Terminated |
NCT01408641 -
Topiramate for Alcohol Use in Posttraumatic Stress Disorder
|
N/A | |
Active, not recruiting |
NCT01182766 -
New Treatment for Alcohol and Nicotine Dependence
|
Phase 2/Phase 3 | |
Completed |
NCT02193204 -
Chronic Alcohol, Stress Inflammatory Response and Relapse Risk
|
N/A | |
Completed |
NCT01342549 -
Treatment Strategy for Alcohol Use Disorders in Veterans With TBI
|
Phase 3 | |
Completed |
NCT01176591 -
HBPL Study of the Impact of the NK1 Antagonist Aprepitant
|
Phase 2 | |
Completed |
NCT01165541 -
A Study of Quetiapine and Mirtazapine for the Treatment of Alcohol Dependency
|
Phase 2 | |
Completed |
NCT01056484 -
Mindfulness Meditation for Health
|
Phase 2 | |
Completed |
NCT00585780 -
Prazosin to Reduce Stress-Induced Alcohol/Drug Craving and Relapse
|
Phase 1/Phase 2 | |
Completed |
NCT00607620 -
Disseminating Organizational SBI Services at Trauma Centers
|
N/A | |
Completed |
NCT00884884 -
Aripiprazole and Topiramate on Free-Choice Alcohol Use
|
Phase 2/Phase 3 | |
Completed |
NCT00463346 -
Treatment With Acamprosate in Patients With Schizophrenia and Comorbid Alcoholism
|
Phase 3 |